BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 36121650)

  • 1. Serum IgG N-glycans enable early detection and early relapse prediction of colorectal cancer.
    Gu Y; Duan B; Sha J; Zhang R; Fan J; Xu X; Zhao H; Niu X; Geng Z; Gu J; Huang B; Ren S
    Int J Cancer; 2023 Feb; 152(3):536-547. PubMed ID: 36121650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of IgG N-glycome profile in colorectal cancer progression by MALDI-TOF-MS.
    Liu S; Cheng L; Fu Y; Liu BF; Liu X
    J Proteomics; 2018 Jun; 181():225-237. PubMed ID: 29698801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic alterations in serum IgG N-glycan profiles in the development of colitis-associated colon Cancer in mouse model.
    Gu Y; Han J; Liu X; Pan Y; Xu X; Sha J; Ren S; Gu J
    Biochim Biophys Acta Gen Subj; 2020 Oct; 1864(10):129668. PubMed ID: 32553689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring serum and immunoglobulin G N-glycome as diagnostic biomarkers for early detection of breast cancer in Ethiopian women.
    Gebrehiwot AG; Melka DS; Kassaye YM; Gemechu T; Lako W; Hinou H; Nishimura SI
    BMC Cancer; 2019 Jun; 19(1):588. PubMed ID: 31208374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical utility of a serum glycome analysis in patients with colorectal cancer.
    Takei D; Harada K; Nouso K; Miyahara K; Dohi C; Matsushita H; Kinugasa H; Hiraoka S; Nishimura SI; Okada H
    J Gastroenterol Hepatol; 2022 Apr; 37(4):727-733. PubMed ID: 35064597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic Potential of Plasma IgG N-glycans in Discriminating Thyroid Cancer from Benign Thyroid Nodules and Healthy Controls.
    Zhang Z; Wu J; Liu P; Kang L; Xu X
    Front Oncol; 2021; 11():658223. PubMed ID: 34476207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Profiling of isomer-specific IgG N-glycosylation in cohort of Chinese colorectal cancer patients.
    Liu S; Huang Z; Zhang Q; Fu Y; Cheng L; Liu BF; Liu X
    Biochim Biophys Acta Gen Subj; 2020 Mar; 1864(3):129510. PubMed ID: 31887339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Volatile organic compounds in breath can serve as a non-invasive diagnostic biomarker for the detection of advanced adenomas and colorectal cancer.
    van Keulen KE; Jansen ME; Schrauwen RWM; Kolkman JJ; Siersema PD
    Aliment Pharmacol Ther; 2020 Feb; 51(3):334-346. PubMed ID: 31858615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel DNA methylation biomarkers in stool and blood for early detection of colorectal cancer and precancerous lesions.
    Shen Y; Wang D; Yuan T; Fang H; Zhu C; Qin J; Xu X; Zhang C; Liu J; Zhang Y; Wen Z; Tang J; Wang Z
    Clin Epigenetics; 2023 Feb; 15(1):26. PubMed ID: 36803423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycosylation of plasma IgG in colorectal cancer prognosis.
    Theodoratou E; Thaçi K; Agakov F; Timofeeva MN; Štambuk J; Pučić-Baković M; Vučković F; Orchard P; Agakova A; Din FV; Brown E; Rudd PM; Farrington SM; Dunlop MG; Campbell H; Lauc G
    Sci Rep; 2016 Jun; 6():28098. PubMed ID: 27302279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Proton nuclear magnetic resonance spectroscopy recognition of metabolic patterns in fecal extracts for early diagnosis of colorectal cancer].
    Lin Y; Wang ZN; Ma CC; Liu CK; Yang JR; Shen ZW; Wu RH
    Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Sep; 50(9):788-793. PubMed ID: 27655598
    [No Abstract]   [Full Text] [Related]  

  • 12. Screening and diagnosis of colorectal cancer and advanced adenoma by Bionic Glycome method and machine learning.
    Pan Y; Zhang L; Zhang R; Han J; Qin W; Gu Y; Sha J; Xu X; Feng Y; Ren Z; Dai J; Huang B; Ren S; Gu J
    Am J Cancer Res; 2021; 11(6):3002-3020. PubMed ID: 34249441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiplex quantitation of 270 plasma protein markers to identify a signature for early detection of colorectal cancer.
    Bhardwaj M; Weigl K; Tikk K; Holland-Letz T; Schrotz-King P; Borchers CH; Brenner H
    Eur J Cancer; 2020 Mar; 127():30-40. PubMed ID: 31972396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a 92 multiplex protein panel in detection of colorectal cancer and high-risk adenoma in 784 symptomatic individuals.
    Rasmussen L; Nielsen HJ; Christensen IJ
    Cancer Biomark; 2021; 32(1):73-84. PubMed ID: 34092616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating microRNA-1290 as a novel diagnostic and prognostic biomarker in human colorectal cancer.
    Imaoka H; Toiyama Y; Fujikawa H; Hiro J; Saigusa S; Tanaka K; Inoue Y; Mohri Y; Mori T; Kato T; Toden S; Goel A; Kusunoki M
    Ann Oncol; 2016 Oct; 27(10):1879-86. PubMed ID: 27502702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proximal fluid proteome profiling of mouse colon tumors reveals biomarkers for early diagnosis of human colorectal cancer.
    Fijneman RJ; de Wit M; Pourghiasian M; Piersma SR; Pham TV; Warmoes MO; Lavaei M; Piso C; Smit F; Delis-van Diemen PM; van Turenhout ST; Terhaar sive Droste JS; Mulder CJ; Blankenstein MA; Robanus-Maandag EC; Smits R; Fodde R; van Hinsbergh VW; Meijer GA; Jimenez CR
    Clin Cancer Res; 2012 May; 18(9):2613-24. PubMed ID: 22351690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A fecal-based test for the detection of advanced adenoma and colorectal cancer: a case-control and screening cohort study.
    Cao LJ; Peng XL; Xue WQ; Zhang R; Zhang JB; Zhou T; Wu ZY; Li GR; Wang TM; He YQ; Yang DW; Liao Y; Tong XT; Wang F; Chen KX; Zhang SH; Zhu LQ; Ding PR; Jia WH
    BMC Med; 2021 Oct; 19(1):250. PubMed ID: 34689777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specificity of metabolic colorectal cancer biomarkers in serum through effect size.
    Di Giovanni N; Meuwis MA; Louis E; Focant JF
    Metabolomics; 2020 Aug; 16(8):88. PubMed ID: 32789702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum netrin-1 as a biomarker for colorectal cancer detection.
    Li B; Shen K; Zhang J; Jiang Y; Yang T; Sun X; Ma X; Zhu J
    Cancer Biomark; 2020; 28(3):391-396. PubMed ID: 32474463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-Hydroxymethylcytosine signature in circulating cell-free DNA as a potential diagnostic factor for early-stage colorectal cancer and precancerous adenoma.
    Xiao Z; Wu W; Wu C; Li M; Sun F; Zheng L; Liu G; Li X; Yun Z; Tang J; Yu Y; Luo S; Sun W; Feng X; Cheng Q; Tao X; Wu S; Tao J
    Mol Oncol; 2021 Jan; 15(1):138-150. PubMed ID: 33107199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.